The cancer/tumor profiling market size is projected to reach $87.1 billion by 2023, growing at a CAGR of 19.0% during 2017-2023. The market is growing mainly due to the increasing number of new cancer cases, rising utility of biomarkers in tumor profiling, rising availability of funding for cancer research and increasing demand for next generation sequencing for cancer profiling. Request for report sample at: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market/report-sample The players in the market are developing different biomarkers based on what is to be detected in a patient. For instance, Caris Life Sciences, develops several biomarkers that are based on IHC, that detects the level of protein expression, translocations and fusions, ISH, amplifications, detects gene deletions, NGS, rapidly examines and more broadly detects DNA mutations, copy number variations and gene fusions across the genome, and fragment analysis, that detects changes in RNA or DNA to indicate the absence or presence of genetic marker. Due to this precise detection using biomarkers for the cancer-causing agent, there is an increase in the use of biomarkers for cancer profiling and thereby driving the growth of the cancer/tumor profiling market. Europe held the second largest share of 27.7% in the global cancer/tumor profiling market in 2016. The growth in the European market for cancer/tumor profiling is mainly led by growing aging population, increasing prevalence of chronic pain, and neurological disorders and R&D infrastructure. By 2023, the European market for cancer/tumor profiling is expected to cross $23.0 billion dollar, growing at a CAGR of 18.5% between 2017-2023. Among all the European countries, Germany held the largest share in the European cancer/tumor profiling industry and is expected to register a CAGR of 19.3% in the forecast period. Explore Report at: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market Some of the other key players operating in the cancer/tumor profiling market include Illumina, Inc., NeoGenomics Inc., Caris Life Sciences, Inc., Oxford Gene Technology, HTG Molecular Diagnostics, Inc., RiboMed Biotechnologies, Inc., QIAGEN N.V. and NanoString Technologies, Inc.
0 Comments
According to a recent research report by P&S Intelligence, the global cleanroom technology size is projected to reach $5.0 billion by 2023. Various factors leading to the growth of the global cleanroom technology market include increasing demand for certified products, technological advancements in cleanrooms, growing prevalence of infectious diseases etc. Request for report sample at: https://www.psmarketresearch.com/market-analysis/cleanroom-technology-market/report-sample With the increased number of biological products coming to the market, new practices to provide high assurance on pharmaceutical sterilization processes have become necessary. At the same time, changes in the type of materials and products required in manufacturing of pharmaceuticals are forcing the companies to make changes in typical sterilization methods leading to increase in cleanroom technology products. The WHO has set some parameters for making sterilized pharmaceutical products such as quality control, sanitation, manufacture of sterile preparation, isolator technology, and blow/fill/seal technology to avoid any contamination. Thus, the increasing demand for sterilized pharmaceutical products leads to a positive impact on the cleanroom technology market. Geographically, North America is the largest market for cleanroom technology, driven by increased adoption of these products and technological advancements in the cleanroom technology products offered in the region. The increased government initiatives for the development and marketing of better quality products, that are efficient and safe to use are likely to fuel the growth of the market in North America. Furthermore, cleanroom technology has wide applications in pharmaceuticals, medical devices, and biotechnology industries, as well as hospitals and several research laboratories. It is estimated that around 722,000 hospital-acquired infection cases were reported in the U.S. during 2011, and around 75,000 patients died during their hospitalization in the same year. These infections can be prevented by efficient use of safety and cleaning consumables, such as gloves, bleaching wipes, and disinfectants. Therefore, the increasing demand for safety and cleaning consumables is likely to drive market demand. Browse full report at: https://www.psmarketresearch.com/market-analysis/cleanroom-technology-market Kimberly-Clark Corporation is the global leader in the cleanroom technology market and held 32.7% share in 2016. The company offers products such as surgical solutions, surgical gowns, clinical towels, medical gloves, disinfectants, soap sanitizers, baby wipes, facial and bathroom tissues, and paper towels. Illinois Tool Works Inc. is another major player in the global cleanroom technology market, which markets industrial products and equipment, such as electronic assembly equipment, plastic and metal components, static control equipment, adhesives, hand wipes, and cleaners. 4/10/2019 Demand for Mass Spectrometry is Growing Rapidly In Life Science and Clinical Sector is Driving the Growth of the MarketRead NowThe demand for mass spectrometry is growing rapidly in life science and clinical sector. Some of its most common applications in life science and clinical studies are determination of protein structure, interactions and folding; protein identification from the mass of its peptide fragment; relative or absolute quantification of proteins in a given sample; monitoring of enzyme reactions; chemical modifications; protein digestion; forensic analysis; and disease biomarkers detection. All these applications are very vital in life science and clinical studies and with increasing healthcare awareness, advanced research and development, increasing cases of drug abuse, and high number of metabolic diseases, the demand for mass spectrometer is rapidly growing. Mass spectrometer is an important analytical tool for the study of proteins. Proteomics is very difficult to analyse and study, due to the complexity of its structures. Mass spectrometry helps to analyse the composition of different biological samples and offers quantitative proteogenomics and proteomics. All these factors tend to drive the growth of the mass spectrometry market. Explore report sample at@ https://www.psmarketresearch.com/market-analysis/mass-spectrometry-market/report-sample Europe had the second largest share in the mass spectrometry market in 2015, with 26.0% share. Increasing food safety concern, growing demand in life science & clinical analysis sector and technological advancements are the key growth drivers of the European market. High compliance with international GMP & GDP certification for pharmaceutical excipients has high positive impact on the European market for mass spectrometry. Forensic science and new product development offer ample growth opportunities for the European market. Browse full report at@ https://www.psmarketresearch.com/market-analysis/mass-spectrometry-market The key companies operating in the mass spectrometry market include Danaher Corporation, Shimadzu Corporation, Thermo Fisher Scientific Inc., Bruker Corporation, Agilent Technologies Inc., Waters Corporation, PerkinElmer Inc., LECO Corporation, Dani Instruments S.p.A, Protea Biosciences Group Inc., Microsaic Systems PLC, Endress+Hauser Inc., Jeol USA Inc., and Elico Ltd. Source: P&S Intelligence
The clinical decision support system market size is expected to cross $1.5 billion by 2022, growing at a CAGR of 21.5% between 2016-2022. The CDSS market is driven by five major factors, including growing demand for advanced healthcare information systems, growing investments by HIT players, growing need for remote patient monitoring services, and increasing support from government organizations. Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/clinical-decision-support-system-market/report-sample The massive unexplored CDSS across the globe has created abundant opportunities for the major players to exploit the potential of the CDSS market. Although, there has been significant development in the developed economies of European Union (EU) and the U.S., the clinical decision support system market is still at its nascent form, especially in the developing countries of Asia, Latin America, and Africa. A high growth in numbers of end user including hospitals, and pharmacy has been witnessed in the developing countries of these regions, which provides immense growth opportunities for the CDSS market. The Asia-Pacific market for CDSS is expected to grow at a CAGR of 23.2% between 2016-2022. The clinical decision support system market in Asia-Pacific is growing, due to growing geriatric population and upsurge in the occurrence rate of different chronic diseases. In addition, the improving healthcare infrastructure, and favorable government support, such as investments and grants has fueled the demand of HIT systems including CDSS in the region. China is expected to grow at a CAGR of 27% during the forecast period and reach $114.3 million by 2022, in the Asia-Pacific CDSS market. Explore Report at: https://www.psmarketresearch.com/market-analysis/clinical-decision-support-system-market Some of the key companies operating in the CDSS market include Cerner Corporation, RELX Group PLC, Epic Systems Corporation, General Electric Company, McKesson Corporation, Zynx Health Incorporated, International Business Machine Corporation, Siemens AG, Allscripts Healthcare Solutions Inc., Meditech and Wolters Kluwer. The oligonucleotide synthesis market size is set to cross $2.7 billion by 2023. The oligonucleotide synthesis industry is driven by factors such as recent advances in oligonucleotide synthesis, increasing support from government organizations, increasing research activities in synthetic biology, and increasing burden of cancer and infectious diseases. Request for Sample Copy of this Research Report: https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market/report-sample In terms of application, the oligonucleotide synthesis market is categorized into research, diagnostic and therapeutic. Research has been the largest segment of the market, where it was estimated to contribute 65.2% to the market in 2016. Diagnostic segment is expected to contribute 21.0% revenue to the market in 2023. Based on end user, the oligonucleotide synthesis market is categorized into academic research, diagnostic laboratory, pharmaceutical & biotechnology companies, and others. The other end users of oligonucleotide synthesis products include, but are not limited to, food and beverage companies and forensic laboratories. The contribution of academic research institute to the global market was estimated at 42.0% in 2016. The market in diagnostic laboratories are expected to grow at a CAGR of 10.9% during the forecast period. Browse report at: https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market Some of the key players in the oligonucleotide synthesis market include LGC Biosearch Technologies, Inc., Bioautomation Corporation, Integrated DNA Technologies, Inc., GeneDesign, Inc., Trilink Biotechnologies LLC, Merck KGaA, Eurofins Scientific SE, Thermo Fisher Scientific Inc., General Electric Company and Eurogentec S.A. The wound care market is growing due to increasing geriatric population, increase in volume of sugeries and increasing awareness about wound care products. Increasing cases of diabetes leading to pressure ulcer formation is further generating an increased demand for wound care products. Browse report sample at: https://www.psmarketresearch.com/market-analysis/wound-care-market/report-sample Among the types of wound care products, advanced wound care products segment is expected to witness the fastest growth during the forecast period. Among the various applications, surgical wounds segment accounted for the largest share in the global market in 2015, and it is expected to witness 7.1% CAGR during 2016 – 2022. In 2015, North America held the largest share in the global wound care market whereas, Asia-Pacific market is expected to witness fastest growth, with a CAGR of 7.2% during the period 2016– 2022. Wound care products promote the wound healing process and reduces the recovery time. These products are sterile in nature and prevent the contamination of wounds during the treatment. Traditional wound dressings are generally used to treat acute wounds by promoting wound healing process. They help absorbing exudates, inhibiting infection, preventing bleeding and drying of the wounds. The advanced wound dressings are used to treat chronic wounds, which fail to heal properly in timely manner. Advanced wound dressings include foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings and others. Browse report at: https://www.psmarketresearch.com/market-analysis/wound-care-market Some of the key companies operating in the global wound care market include 3M Company, Coloplast Corporation, Medtronic plc, Smith and Nephew plc, ConvaTec, Johnson and Johnson, Integra Life Sciences Holdings Corporation, Molyncke Health Care, Mo-Sci Corporation, Organogenesis Inc., Acelity L.P. Inc., DermaRite Industries LLC., Derma Sciences Inc., Hollister Incorporated and DeRoyal Industries Inc. The global eClinical solution market is growing, due to increasing number of clinical trials and increasing spends on clinical research and development in the pharmaceutical and biotechnology industry. In addition, the growing clinical trial outsourcing and increasing need for improved data standardization are also driving the growth of the global market. Browse report sample at: https://www.psmarketresearch.com/market-analysis/e-clinical-solutions-market/report-sample Among the various end users, the pharmaceutical and biotechnology segment is expected to be the largest market; while the clinical research organizations segment, with a CAGR of 16.1%, is expected to witness the fastest growth during the forecast period. The increasing number of clinical trials and growing clinical trial outsourcing are playing a pivotal role in the growth of the global market. E-clinical solution in the study refer to software that is used to accelerate the clinical development process. It comprises of various professional services and products, such as clinical data management system (CDMS), clinical trial management system (CTMS), safety solution, electronic clinical outcome assessment (eCOA) solution, and randomization and trial supply management (RTSM) solution. Browse report at: https://www.psmarketresearch.com/market-analysis/e-clinical-solutions-market In 2014, North America dominated the global market of e-clinical solution, whereas the Asia-Pacific market is expected to witness the fastest growth, with a CAGR of 17.9%, during the forecast period. The key companies operating in the global e-clinical solution market include Oracle Corporation, PAREXEL International Corporation, OmniComm Systems Inc., ERT, BioClinica, CRF Health Inc., Medidata Solutions, and DATATRAK International Inc. The global synthetic biology market is growing, due to increasing support from government organizations, and growing geriatric population. In addition, the innovative and advanced applications of synthetic biology, increasing research activities, and increasing R&D investments in drug discovery and development are also supporting the growth of this market.
The European sleeping aids market was valued at $14.8 billion in 2015 and is forecasted to grow at a CAGR of 6.2% during 2016-2022. Various sleep disorders are hampering the lives of people in the region, due to increasing tobacco and alcohol consumption, rising aging population, growing population base working in night shifts and changing lifestyle habits of the Europeans. Sleep disorders such as insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleep walking and others greatly affect the population base in the European region. Browse report sample at: https://www.psmarketresearch.com/market-analysis/europe-sleeping-aids-market/report-sample Sleeping aids namely mattress & pillow, sleep laboratories, medication, sleep apnea devices and others are largely used for the above-mentioned sleeping disorders. Mattress & pillows held the largest share in the European sleeping aids market and contributed 43% in 2015. Amongst all the sleep related problems people are being majorly affected by insomnia and sleep apnea in the Europe. Increasing awareness about sleep disorders and risks associated with them, by various organizations such as the British Sleep Society and Survey Sleep Research Center has been driving the demand of the sleeping aids products in the region. According to the Eurostat, aging population is a long-term trend in the region, this is also a key factor driving the demand for sleeping aids in the region. The share of population aged 65 years and over is increasing in every European Union (EU) member state. During the period 2016 to 2080 the aging population is expected to account for a share of 29.1% of the EU-28 population compared to 19.2% in 2016. Browse report at: https://www.psmarketresearch.com/market-analysis/europe-sleeping-aids-market There are various technological advancements related to sleeping aids products that are under development in the region. For instance, an application known as Snoozeal has been developed in the U.S. for treating problems related to sleep which is now under trial in the Europe. It is a smartphone controlled anti-snoring/sleep apnea medical device, that has received U.S. Food and Drug Association (USFDA) approval in December 2016. The device addresses the root cause of excessive relaxation and loss of tongue muscle tone during sleep. The device uses a wireless technology to exercise the tongue to treat the physiological cause of snoring and sleep apnea and the smart phone app monitors the user and controls the progress of the treatment. Also, the latest DOMINO version 2.8.0 by Somnomedics Gmbh provides high quality and user-friendly collection and analysis of both the ambulatory (Polysomnography) PSG and the stationary PSG recordings with the SOMNOscreen, SOMNOscreen plus and the new device SOMNO HD and this software was developed in August 2016. Source: P&S Intelligence |
Details
Global Industrial Refrigeration Market Size,Share and Demand Forecast During 2015 – 2020 By P&S Market ResearchThe global industrial refrigeration market is expected to grow from $22,571 million in 2014, and reach $33,904 million in 2020, with a CAGR of 7.1%. Evaporator unit, industrial racks, and compressor together accounted about 64% share of the global industrial refrigeration market in 2014. The growth of food processing industries, in addition to the expansion of refrigerated warehouses in developing countries, such as India, China, and Brazil, is expected to boost the demand of industrial refrigeration during the forecast period. The growth in outsourcing of pharmaceutical manufacturing facility by developed countries has lifted up the demand of pharmaceuticals cold chain supply and logistic in recent years.
Explore Report Description with Detailed TOC on “Global Industrial Refrigeration Equipment” at: https://www.psmarketresearch.com/market-analysis/industrial-refrigeration-equipment-market Industrial refrigeration stereotypically plays an important role among various manufacturing facilities in chemicals, and oil & gas industry. The industrial refrigeration system is an efficient combination of different electrical and mechanical components including compressors, heat exchangers, evaporators, racks and others; while the component used for the system may be in distinct parts, from more than one manufacturer. The parts such as compressor, heat exchangers, and evaporator unit are assembled under a custom engineered system by the installation service providers. The market in Asia–Pacific, Latin America and emerging countries of Middle-East have shown promising growth during the past few years. The European market is heading towards maturity, and it is expected to witness a below average growth during the forecast period. The growth of the industrial refrigeration equipment market in the European countries is mainly anticipated due to replacement of existing industrial refrigeration parts The information and data in the publication “Global Industrial Refrigeration Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Type (Evaporator Unit, Industrial Racks, Compressor, Heat Exchangers, Other Industrial Refrigeration Units)” represent the research and analysis of data from various primary and secondary sources. Both, Top-down and Bottom-up approach has been used to calculate the global Industrial Refrigeration market by type and by technology. The market numbers for countries are obtained through bottom-up approach. P&S Market Research analysts and consultants interact with leading companies of the concerned domain to substantiate every value of data presented in this report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is aided by informed and detailed, online and offline research. Ask Sample Pages: https://www.psmarketresearch.com/market-analysis/industrial-refrigeration-equipment-market/report-sample The major companies operating in the global industrial refrigeration market include. Johnson Controls Inc., Dover Corporation, Hussmann Corporation, Star Refrigeration Ltd., United Technologies Corporation, Danfoss A/S, BITZER Kühlmaschinenbau GmbH, Emerson Electric Co., GEA Group Aktiengesellschaft, and Industrial Frigo S.R.L. INDUSTRIAL REFRIGERATION MARKET SEGMENTATION By Type By Region AuthorAbout P&S Market Research Archives
July 2018
Business |